1|0|Public
50|$|<b>Mofegiline</b> (MDL-72,974) is a selective, {{irreversible}} inhibitor of {{monoamine oxidase}} B (MAO-B) and semicarbazide-sensitive amine oxidase (SSAO) which was {{under investigation for}} the treatment of Parkinson's disease and Alzheimer's disease, but was never marketed.|$|E

